SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Biolase, Inc. – ‘8-K’ for 4/28/22 – ‘EX-3.1’

On:  Monday, 5/2/22, at 7:01am ET   ·   For:  4/28/22   ·   Accession #:  1193125-22-135298   ·   File #:  1-36385

Previous ‘8-K’:  ‘8-K’ on / for 3/17/22   ·   Next:  ‘8-K’ on / for 5/12/22   ·   Latest:  ‘8-K’ on 5/6/24 for 5/2/24   ·   38 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/02/22  Biolase, Inc.                     8-K:5,9     4/28/22   11:180K                                   Donnelley … Solutions/FA

Current Report   —   Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     36K 
 2: EX-3.1      Articles of Incorporation/Organization or Bylaws    HTML     11K 
 6: R1          Document and Entity Information                     HTML     49K 
 9: XML         IDEA XML File -- Filing Summary                      XML     12K 
 7: XML         XBRL Instance -- d330346d8k_htm                      XML     14K 
 8: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 4: EX-101.LAB  XBRL Labels -- biol-20220428_lab                     XML     57K 
 5: EX-101.PRE  XBRL Presentations -- biol-20220428_pre              XML     36K 
 3: EX-101.SCH  XBRL Schema -- biol-20220428                         XSD     12K 
10: JSON        XBRL Instance as JSON Data -- MetaLinks               12±    19K 
11: ZIP         XBRL Zipped Folder -- 0001193125-22-135298-xbrl      Zip     12K 


‘EX-3.1’   —   Articles of Incorporation/Organization or Bylaws


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



  EX-3.1  

Exhibit 3.1

SIXTH AMENDMENT

TO

RESTATED CERTIFICATE OF INCORPORATION

OF

BIOLASE, INC.

BIOLASE, Inc. (the “Corporation”), a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware, hereby certifies as follows:

 

  1.

This Certificate of Amendment amends the provisions of the Corporation’s Restated Certificate of Incorporation, as amended and filed with the Secretary of State of the State of Delaware (the “Restated Certificate of Incorporation”).

 

  2.

Article III of the Restated Certificate of Incorporation is hereby amended and restated in its entirety as follows:

THIRD. The total number of shares of stock which the Corporation shall have the authority to issue is ONE HUNDRED EIGHTY ONE MILLION (181,000,000) shares of which stock ONE HUNDRED EIGHTY MILLION (180,000,000) shares of $.001 par value shall be common stock and of which ONE MILLION (1,000,000) shares of $.001 par value shall be preferred stock.

Upon the filing and effectiveness (the “Effective Time”) pursuant to the General Corporation Law of the State of Delaware of this Sixth Amendment to Restated Certificate of Incorporation of the Corporation, each twenty-five (25) shares of common stock either issued and outstanding or held by the Corporation in treasury stock immediately prior to the Effective Time shall, automatically and without any action on the part of the respective holders thereof, be combined and converted into one (1) share of common stock (the “Reverse Stock Split”).

No fractional shares shall be issued in connection with the Reverse Stock Split. In lieu thereof, the aggregate of all fractional shares otherwise issuable to the holders of record of common stock shall be issued to the transfer agent, as agent for the accounts of all holders of record of common stock and otherwise entitled to have a fraction of a share issued to them. The sale of all of the fractional interests will be effected by the transfer agent as soon as practicable after the Effective Time on the basis of the prevailing market prices of the common stock at the time of the sale. After such sale, the transfer agent will pay to such holders of record their pro rata share of the total net proceeds derived from the sale of the fractional interests.

 

  3.

The foregoing amendment was duly adopted in accordance with the provisions of Section 242 of the General Corporation Law of the State of Delaware.

 

  4.

All other provisions of the Restated Certificate of Incorporation shall remain in full force and effect.

 

  5.

The foregoing amendment shall be effective as of 11:59 p.m., Eastern Time, on the date of filing with the Secretary of State of the State of Delaware.

* * * * *


IN WITNESS WHEREOF, the Corporation has caused this Certificate of Amendment to be signed this 28 day of April, 2022.

 

BIOLASE, INC.
By:  

/s/ Michael C. Carroll

Name:   Michael C. Carroll
Title:   Secretary

38 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/19/24  Biolase, Inc.                     POS AM                 1:1.1M                                   Donnelley … Solutions/FA
 4/11/24  Biolase, Inc.                     POS AM                 3:1.1M                                   Donnelley … Solutions/FA
 3/27/24  Biolase, Inc.                     S-1/A                  5:1.1M                                   Donnelley … Solutions/FA
 3/21/24  Biolase, Inc.                     10-K       12/31/23   99:18M                                    Donnelley … Solutions/FA
 2/09/24  Biolase, Inc.                     S-1/A                  4:3M                                     Donnelley … Solutions/FA
 2/07/24  Biolase, Inc.                     S-1/A                  8:3.3M                                   Donnelley … Solutions/FA
 1/31/24  Biolase, Inc.                     S-1/A                  9:3.2M                                   Donnelley … Solutions/FA
 1/24/24  Biolase, Inc.                     S-8         1/24/24    4:119K                                   Donnelley … Solutions/FA
 1/19/24  Biolase, Inc.                     S-1                    3:2.6M                                   Donnelley … Solutions/FA
12/26/23  Biolase, Inc.                     S-1                    4:496K                                   Donnelley … Solutions/FA
12/08/23  Biolase, Inc.                     424B5                  1:401K                                   Donnelley … Solutions/FA
11/09/23  Biolase, Inc.                     10-Q        9/30/23   81:12M                                    Donnelley … Solutions/FA
 9/11/23  Biolase, Inc.                     S-1/A                  4:868K                                   Donnelley … Solutions/FA
 9/05/23  Biolase, Inc.                     S-1/A       9/01/23    2:830K                                   Donnelley … Solutions/FA
 8/30/23  Biolase, Inc.                     S-1/A                  8:1.3M                                   Donnelley … Solutions/FA
 8/18/23  Biolase, Inc.                     S-1/A                  2:720K                                   Donnelley … Solutions/FA
 8/14/23  Biolase, Inc.                     S-1/A       8/11/23    8:1.3M                                   Donnelley … Solutions/FA
 8/10/23  Biolase, Inc.                     10-Q        6/30/23   85:13M                                    Donnelley … Solutions/FA
 7/21/23  Biolase, Inc.                     S-1                    3:800K                                   Donnelley … Solutions/FA
 5/24/23  Biolase, Inc.                     S-1/A                  7:1.2M                                   Donnelley … Solutions/FA
 5/22/23  Biolase, Inc.                     S-1/A                  8:1.3M                                   Donnelley … Solutions/FA
 5/18/23  Biolase, Inc.                     S-1/A                  8:1.2M                                   Donnelley … Solutions/FA
 5/11/23  Biolase, Inc.                     10-Q        3/31/23   81:9.9M                                   Donnelley … Solutions/FA
 5/04/23  Biolase, Inc.                     S-1                    3:750K                                   Donnelley … Solutions/FA
 3/28/23  Biolase, Inc.                     10-K       12/31/22   90:19M                                    Donnelley … Solutions/FA
 1/11/23  Biolase, Inc.                     424B1                  1:624K                                   Donnelley … Solutions/FA
 1/03/23  Biolase, Inc.                     S-1/A                  6:1M                                     Donnelley … Solutions/FA
12/12/22  Biolase, Inc.                     S-1/A                  7:1.1M                                   Donnelley … Solutions/FA
11/22/22  Biolase, Inc.                     S-1                    3:655K                                   Donnelley … Solutions/FA
11/10/22  Biolase, Inc.                     10-Q        9/30/22   83:14M                                    Donnelley … Solutions/FA
 8/19/22  Biolase, Inc.                     S-3/A                  3:281K                                   Donnelley … Solutions/FA
 8/19/22  Biolase, Inc.                     424B3                  1:126K                                   Donnelley … Solutions/FA
 8/17/22  Biolase, Inc.                     S-3/A                  2:183K                                   Donnelley … Solutions/FA
 8/12/22  Biolase, Inc.                     S-3                    5:724K                                   Donnelley … Solutions/FA
 8/11/22  Biolase, Inc.                     10-Q        6/30/22   83:16M                                    Donnelley … Solutions/FA
 8/08/22  Biolase, Inc.                     S-3                    4:207K                                   Donnelley … Solutions/FA
 6/29/22  Biolase, Inc.                     424B5                  1:399K                                   Donnelley … Solutions/FA
 5/12/22  Biolase, Inc.                     10-Q        3/31/22   81:10M                                    Donnelley … Solutions/FA
Top
Filing Submission 0001193125-22-135298   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., May 9, 4:59:13.4am ET